EP
LMAT icon

Essential Partners’s LeMaitre Vascular LMAT Stock Holding History

Essential Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$165 Hold
2
– – ﹤0.01% 2631
2026
Q2 		$192 Hold
2
– – ﹤0.01% 2646
2026
Q1 		$218 Hold
2
– – ﹤0.01% 2589
2025
Q4 		$162 Hold
2
– – ﹤0.01% 2469
2025
Q3 		$175 Sell
2
-1
-33% -$89 ﹤0.01% 2417
2025
Q2 		$249 Buy
+3
New +$251 ﹤0.01% 1896

Other funds holding LMAT

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Chatham Capital Group
Chatham Capital Group Savannah, Georgia $777M AUM 22.3% 1-Year Est. Return
Annex Advisory Services
Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
PFM
Peak Financial Management Wellesley, Massachusetts $441M AUM 13.88% 1-Year Est. Return
Sheets Smith Wealth Management
Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Essential Partners's LMAT Position: Q3 2026 in Review

Essential Partners held its LeMaitre Vascular (LMAT) position steady in Q3 2026 at 2 shares worth $165. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Essential Partners first reported a position in LMAT in Q2 2025 and has held it in 6 quarters since. The position peaked at $249 in Q2 2025. 22 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Essential Partners held 2 shares of LeMaitre Vascular worth $165 as of Q3 2026.
  • Essential Partners left its LeMaitre Vascular share count unchanged in Q3 2026.
  • LeMaitre Vascular made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2631 holding.
  • Essential Partners first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's LeMaitre Vascular position peaked at $249 in Q2 2025.
  • 22 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.